- Home
- NEXM vs SRTS Comparison
NEXM vs SRTS Comparison
Compare NEXM & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEXM | SRTS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.1M | 45.6M |
| IPO Year | 2002 | 2016 |
Fundamental Metrics
Financial Performance| Metric | NEXM | SRTS |
|---|---|---|
| Price | $1.20 | $3.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.38 |
| AVG Volume (30 Days) | 36.2K | ★ 518.8K |
| Earning Date | 11-24-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1044.00 | N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $47.33 |
| P/E Ratio | $1.90 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $2.66 |
| 52 Week High | $4.71 | $5.49 |
Technical Indicators
Market Signals| Indicator | NEXM | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 30.60 | 63.87 |
| Support Level | N/A | $2.80 |
| Resistance Level | $2.39 | $3.71 |
| Average True Range (ATR) | 0.11 | 0.44 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 7.69 | 27.24 |
Price Performance
Historical ComparisonAbout NEXM NexMetals Mining Corp.
NexMetals Mining Corp is a mineral exploration and development company focused on discovering and advancing high-quality copper-nickel-cobalt-platinum element metals (Cu- Cu-Ni-Co-PGE) resources. The group prioritizes projects in stable, mining-friendly jurisdictions with supportive foreign investment and rule-of-law standards. Its projects are Botswana and Canada.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.